Shares of Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) were up 8.2% during mid-day trading on Thursday . The stock traded as high as $104.50 and last traded at $106.4690. Approximately 72,786 shares traded hands during trading, a decline of 82% from the average daily volume of 414,616 shares. The stock had previously closed at $98.36.
Analyst Ratings Changes
Several equities analysts recently issued reports on BLLN shares. Wall Street Zen raised Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. Weiss Ratings raised Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday, May 15th. Wells Fargo & Company reduced their price objective on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a report on Thursday, March 5th. JPMorgan Chase & Co. lifted their price objective on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Finally, BTIG Research reduced their price objective on Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Six analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $125.29.
Check Out Our Latest Stock Analysis on Billiontoone
Billiontoone Stock Up 7.8%
Billiontoone (NASDAQ:BLLN – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million for the quarter, compared to analysts’ expectations of $95.81 million. The business’s quarterly revenue was up 83.8% on a year-over-year basis. During the same period in the previous year, the business posted ($0.39) EPS. Research analysts anticipate that Billiontoone, Inc. will post 0.93 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Billiontoone
Several hedge funds have recently bought and sold shares of the stock. Perceptive Advisors LLC increased its position in Billiontoone by 26.1% during the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock worth $7,248,000 after buying an additional 19,000 shares in the last quarter. Bank of America Corp DE grew its position in shares of Billiontoone by 8,603.4% in the first quarter. Bank of America Corp DE now owns 12,707 shares of the company’s stock valued at $1,003,000 after purchasing an additional 12,561 shares during the period. The Manufacturers Life Insurance Company grew its position in shares of Billiontoone by 151.8% in the first quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock valued at $2,408,000 after purchasing an additional 18,389 shares during the period. Renaissance Technologies LLC purchased a new stake in shares of Billiontoone in the first quarter valued at $4,046,000. Finally, Public Employees Retirement System of Ohio purchased a new stake in shares of Billiontoone in the first quarter valued at $1,539,000.
About Billiontoone
BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.
BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.
Featured Stories
- Five stocks we like better than Billiontoone
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
- Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?
- The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker
- Before the IPO: 4 Companies That Rewarded Investors Who Got In Early
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
-ltd-logo-1200x675.jpg){kind=logo}
